Original article: cardiovascular
Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures

Presented at the Thirty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 31–Feb 2, 2003.
https://doi.org/10.1016/j.athoracsur.2003.06.019Get rights and content

Abstract

Background

Current practice, trends, and early outcomes in patients undergoing surgical and percutaneous coronary interventions (PCI) are changing and subject to speculation.

Methods

148,396 consecutive patients in 69 HCA, Inc hospitals who underwent either PCI or coronary artery bypass grafting (CABG) were tracked in the HCA Casemix Database from 1999 through the first quarter of 2002. Comorbid conditions, procedures, complications, and outcome variables were defined through International Classification of Diseases, Ninth Revision coding. Odds ratios (OR) for death and other procedure-related complications were estimated using logistic regression adjusting for age, sex, and 31 other patient clinical and procedural characteristics.

Results

Now 65.4% of all coronary revascularization is by PCI with a 6.8% annual rate of increase whereas CABG volume is declining by 1.9% per year. However the majority of these changes occurred between 1999 and 2000 with only small changes in the last 3 years. Coronary artery bypass grafting is still utilized primarily for multivessel disease (3.38 bypasses per patient) whereas PCI is predominately (83%) still limited to single-vessel intervention. Unadjusted mortality rates over the full 13-quarter period were 1.25% for PCI and 2.63% for CABG (p < 0.001), with PCI rates remaining constant and CABG mortality declining. Twenty-three percent of CABG is performed off pump with a lower mortality than conventional on-pump CABG (2.37% versus 2.69%, p < 0.001). Percutaneous coronary intervention patients have lower mortality (OR 0.51), and fewer acute renal failure (OR 0.39), neurologic (OR 0.12), and cardiac (OR 0.16) complications than CABG patients (p < 0.001).

Conclusions

Interventions for coronary artery disease continue to rise primarily due to an increase in PCI. The volume of PCI continues to increase relative to CABG. Although adverse outcomes are higher after CABG, the proportion of multivessel disease treated is greater. The difference in adverse outcomes between CABG and PCI remains small and continues to decline.

Section snippets

Hospital system

A nationwide for-profit healthcare system, HCA, Inc, involves 200 hospitals in 23 states [4]. A total of 76 hospitals in 17 states had cardiac surgery and interventional cardiology programs between 1999 and 2002. During the study period some hospitals (n = 7) with cardiac surgical and catheterization programs either left the hospital system, ceased performing the procedures, or began new programs. Each hospital had to perform both CABG and PCI patients in each year to be included in the

Results

During the study period from January 1, 1999 to March 31, 2002, a total of 154,701 coronary revascularization procedures were performed in all HCA hospitals. Excluded were 5,305 revascularization procedures not meeting study criteria, leaving 148,396 patients who are the subject of this analysis (Table 1). Of these patients 51,351 (34.6%) underwent CABG and 97,045 (65.4%) underwent PCI. Overall revascularization volumes increased during the study period from 42,678 in 1999 to an annualized

Comment

This study is a comprehensive review of a large population of patients that is representative of current coronary revascularization practice. The strength of this study lies in its representation of the current, real world, community-based practice.

There are, however, potential shortcomings of this study. First, it is based on an administrative rather than a clinical data; therefore particular detailed clinical data are not available which might explain differences. However, outcomes of “hard”

References (9)

  • Society of Thoracic Surgeons. STS National database executive summary. Available at:...
  • American College of Cardiology. ACC Database executive summaries. Available at:...
  • The State of New York heart disease data. Available at: http://health.state.ny.us/nysdoh/heart/heart_disease.htm....
  • HCA, Inc. Investor relations—corporate profile. Available at: http://hca.healthcare.com. Accessed on January 22,...
There are more references available in the full text version of this article.

Cited by (113)

  • Our modified technique of combined antegrade-vein graft cardioplegia infusion versus conventional antegrade method in coronary artery bypass grafting. A randomized clinical trial

    2018, International Journal of Surgery
    Citation Excerpt :

    As implied by the p values, the difference between the intervention and control group in terms of low output syndrome parameters is more remarkable in these two higher-risk subgroups of patients. Currently, most CABGs are performed using cardiopulmonary bypass, worldwide [16]. In spite of spectacular advances in the cardioprotection techniques, postoperative myocardial dysfunction remains by far, the most common cause of death following bypass surgery [17,18].

  • Prolonged pulmonary support after cardiac surgery: Incidence, risk factors and outcomes: A retrospective cohort study

    2015, Journal of Critical Care
    Citation Excerpt :

    While rare (0.4%-2.5%), these retrospective reports may underestimate the true incidence of pulmonary dysfunction after cardiac surgery [4]. A more recent multicenter, prospective study diagnosed 10% of patients after cardiac surgery with ARDS, and the associated morbidity was far higher than that of unaffected patients [5,7]. In fact, perioperative organ injury may be the third leading cause of death in the United States [8].

  • Intraoperative ventilation strategy during cardiopulmonary bypass attenuates the release of matrix metalloproteinases and improves oxygenation

    2015, Journal of Surgical Research
    Citation Excerpt :

    However, the triggered immune response characterized by intraoperative and postoperative elevation of both proinflammatory and anti-inflammatory mediators [2–7] could potentially lead to multiple organ dysfunction and favor adverse outcome. Approximately 10%–25% of patients after CPB develop mild respiratory dysfunction [8], and up to 2%–5% of patients after on-pump procedures are at risk to develop severe lung dysfunction most likely as a consequence of the systemic immune response [1,9]. Therefore, different strategies have been investigated to prevent systemic immune activation during cardiac surgery.

View all citing articles on Scopus
View full text